Company Scilex Holding Company

Equities

SCLX

US80880W1062

Pharmaceuticals

Market Closed - Nasdaq 03:59:51 2024-02-22 pm EST 5-day change 1st Jan Change
1.74 USD -1.69% Intraday chart for Scilex Holding Company +3.57% -14.71%

Business Summary

Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA, a Phase 3, viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica; SP-103 5.4%, a Phase 2, triple-strength formulation of ZTlido, for the treatment of low back pain; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia in multiple Phase 1 program.

Number of employees: 109

Sales per Business

USD in Million2021Weight2022Weight Delta
Non-Opioid Pain Management Products
100.0 %
- - 38 100.0 % -

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
0 nan % 38 100.0 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 216,011,571 92,824,901 ( 42.97 %) 60,068,585 ( 27.81 %) 37.88 %
Stock B 0 29,057,097 0 0

Shareholders

NameEquities%Valuation
SCLX Stock Acquisition JV LLC
38.04 %
60,068,585 38.04 % 99 M $
7,396,247 4.684 % 12 M $
BlackRock Advisors LLC
4.001 %
6,317,169 4.001 % 10 M $
Vanguard Global Advisers LLC
2.490 %
3,932,508 2.490 % 6 M $
1,917,210 1.214 % 3 M $
Geode Capital Management LLC
0.6350 %
1,002,768 0.6350 % 2 M $
Northern Trust Global Investments Ltd.
0.4033 %
636,834 0.4033 % 1 M $
D.E. Shaw & Co., Inc.
0.3971 %
627,038 0.3971 % 1 M $
Rafferty Asset Management LLC
0.3927 %
620,131 0.3927 % 1 M $
Henry Ji
0.3838 %
605,996 0.3838 % 993 833 $
NameEquities%Valuation
Cruiser Capital Advisors LLC
0.3795 %
49,999 0.3795 % 24 650 $
Landscape Capital Management LLC
0.3326 %
43,824 0.3326 % 21 605 $
JPMorgan Alternative Asset Management, Inc.
0.2277 %
30,000 0.2277 % 14 790 $
Accelerate Financial Technologies, Inc.
0.1662 %
21,894 0.1662 % 10 794 $
HRT Financial LLC
0.0999 %
13,162 0.0999 % 6 489 $
Clear Street LLC
0.0188 %
2,480 0.0188 % 1 223 $
Tower Research Capital LLC
0.003172 %
418 0.003172 % 206 $

Company contact information

Scilex Holding Co.

960 San Antonio Road

94303, Palo Alto

+

http://www.scilexholding.com
address Scilex Holding Company(SCLX)
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer